Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN952050 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Eukaryotic Translation Initiation Factor 3 Subunit H (EIF3H) (AA 69-99), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- Affinity chromatography on Protein A
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 69-99, N-Term
- Vial size
- 0.4 mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Genetic heterogeneity in colorectal cancer associations between African and European americans.
The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancer.
An empirical framework for binary interactome mapping.
MYC and EIF3H Coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib.
Mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor eIF3.
Kupfer SS, Anderson JR, Hooker S, Skol A, Kittles RA, Keku TO, Sandler RS, Ellis NA
Gastroenterology 2010 Nov;139(5):1677-85, 1685.e1-8
Gastroenterology 2010 Nov;139(5):1677-85, 1685.e1-8
The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancer.
Hawken SJ, Greenwood CM, Hudson TJ, Kustra R, McLaughlin J, Yang Q, Zanke BW, Little J
Human genetics 2010 Jul;128(1):89-101
Human genetics 2010 Jul;128(1):89-101
An empirical framework for binary interactome mapping.
Venkatesan K, Rual JF, Vazquez A, Stelzl U, Lemmens I, Hirozane-Kishikawa T, Hao T, Zenkner M, Xin X, Goh KI, Yildirim MA, Simonis N, Heinzmann K, Gebreab F, Sahalie JM, Cevik S, Simon C, de Smet AS, Dann E, Smolyar A, Vinayagam A, Yu H, Szeto D, Borick H, Dricot A, Klitgord N, Murray RR, Lin C, Lalowski M, Timm J, Rau K, Boone C, Braun P, Cusick ME, Roth FP, Hill DE, Tavernier J, Wanker EE, Barabási AL, Vidal M
Nature methods 2009 Jan;6(1):83-90
Nature methods 2009 Jan;6(1):83-90
MYC and EIF3H Coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib.
Cappuzzo F, Varella-Garcia M, Rossi E, Gajapathy S, Valente M, Drabkin H, Gemmill R
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009 Apr;4(4):472-8
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009 Apr;4(4):472-8
Mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor eIF3.
Zhou M, Sandercock AM, Fraser CS, Ridlova G, Stephens E, Schenauer MR, Yokoi-Fong T, Barsky D, Leary JA, Hershey JW, Doudna JA, Robinson CV
Proceedings of the National Academy of Sciences of the United States of America 2008 Nov 25;105(47):18139-44
Proceedings of the National Academy of Sciences of the United States of America 2008 Nov 25;105(47):18139-44
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
